1. SAT0129 Improved Quality of Life, Work Productivity, General Activity and Independence in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the Ample Trial. (23rd January 2014) Authors: Fleischmann, R.; Weinblatt, M.; Schiff, M.; Khanna, D.; Rosenblatt, L.; Maldonado, M.; Furst, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0444 Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease. (9th June 2015) Authors: Volkmann, E.; Tashkin, D.; Clements, P.; Roth, M.; Furst, D.; Khanna, D.; Tseng, C.-H.; Arriola, E.; Elashoff, R. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0213 Systemic Sclerosis is Associated with a Unique Colonic Microbial Consortium. (9th June 2015) Authors: Volkmann, E.; Chang, Y.-L.; Barroso, N.; Furst, D.; Clements, P.; Tong, M.; Roth, B.; Conklin, J.; Getzug, T.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0163 Early Response as A Predictor of Long-Term Clinical Response in DMARD-Naïve Patients with Severe, Active and Progressive RA Treated with Certolizumab Pegol plus Optimized MTX versus Optimized MTX Alone. (15th July 2016) Authors: Mariette, X.; Bingham, C.; Burmester, G.-R.; Bykerk, V.P.; Emery, P.; Furst, D.; van der Heijde, D.; van Vollenhoven, R.; VanLunen, B.; Arendt, C.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0396 Double-blind comparison of mycophenolate mofetil and oral cyclophosphamide for treatment of scleroderma-related interstitial lung disease (scleroderma lung study [SLS] II): rationale, design, methods, baseline characteristics and patient disposition. (23rd January 2014) Authors: Khanna, D.; Roth, M.; Furst, D.; Clements, P.; Goldin, J.; Arriola, E.; Kotlerman, J.; Tseng, C.-H.; Kim, G.; Elashoff, R.; Tashkin, D. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0274 Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. (23rd January 2014) Authors: Khanna, D.; Gladue, H.; Fitzgerald, J.; Channick, R.; Chung, L.; Distler, O.; Furst, D.; Hachulla, E.; Humbert, M.; Langelben, D.; Mathai, S.; Saggar, R.; Visovatti, S.; McLaughlin, V. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0228 Validity of Omeract Preliminary Flare Questions in a Randomized Controlled Trial, that Assesses Impact of Disease Activity Guided Down-Titration of Anti-TNF Treatment in Rheumatoid Arthritis Patients in Low Disease Activity. (10th June 2014) Authors: Van Der Maas, A.; van Herwaarden, N.; Woodworth, T.; Minten, M.; Furst, D.; Christensen, R.; den Broeder, A.; Choy, E. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB1239 THE EFFECT OF INFLUENZA VACCINATION ON THE MULTI-BIOMARKER DISEASE ACTIVITY SCORE AND ITS COMPONENT BIOMARKERS IN HEALTHY SUBJECTS. (2nd June 2020) Authors: Furst, D.; Lenz, L.; Horton, M.; Flake, D.; Sasso, E.; Weinblatt, M. E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. AB0550 DIFFUSING CAPACITY OF THE LUNG FOR CARBON MONOXIDE (DLCO) VS FORCED VITAL CAPACITY (FVC): SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS TO EXAMINE THEIR ABILITY TO MEASURE CHANGE IN CLINICAL TRIALS IN SYSTEMIC SCLEROSIS (SSC). (2nd June 2020) Authors: Bellando Randone, S.; Cappellini, E.; Nidiaci, L.; Lepri, G.; Lazzaroni, M. G.; Campochiaro, C.; Bagnato, G.; Sambataro, D.; Sambataro, G.; Matucci-Cerinic, M.; Furst, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0328 SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN SYSTEMIC SCLEROSIS: RESULTS FROM THE OPEN-LABEL PERIOD OF THE PHASE 3 FOCUSSCED TRIAL. (2nd June 2020) Authors: Khanna, D.; Lin, C. J. F.; Spotswood, H.; Siegel, J.; Furst, D.; Denton, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗